ASML:EURONEXT AMSTERDAMASML Holding NV Analysis
Data as of 2026-05-22 - not real-time
$1,592.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
ASML is trading near its 52‑week high and comfortably above both its 20‑day and 200‑day moving averages, with momentum indicators such as an RSI in the upper‑mid‑50s and a bullish MACD crossover confirming continued upward pressure. Volume is on an increasing trend, and the price sits above a solid support level around €1,365 while facing resistance near €1,603, implying a modest upside of roughly 4% based on current levels. Fundamentally, the company posted a 13% revenue increase YoY, maintains a gross margin above 50% and an operating margin near 36%, delivering a robust ROE exceeding 50% and strong free cash flow generation. The balance sheet is healthy with low leverage and a dividend yielding just 0.55% backed by a payout ratio under 30%. Analyst consensus remains a "strong buy" with median price targets around €1,728, yet a discounted cash‑flow model suggests a fair value far below the market price, highlighting a significant valuation premium. Recent material news confirms a Q1 earnings beat and solid order intake, reinforcing the company's growth narrative. While the stock benefits from powerful market positioning in EUV lithography and AI‑related hype, the disparity between market price and intrinsic valuation introduces a cautionary note. Overall, the technical setup is bullish, but the valuation appears stretched, warranting careful consideration of entry timing.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 8/10
Key Factors
- Price above key moving averages and bullish MACD
- Increasing volume supporting momentum
- Support level well‑below current price
Medium Term
1–3 yearsPositive
Model confidence: 9/10
Key Factors
- Strong revenue and earnings growth trajectory
- Dominant market position in EUV lithography
- Robust cash generation and low leverage
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Valuation premium relative to DCF fair value
- Cyclical nature of semiconductor equipment demand
- Sustained competitive moat but potential price correction
Key Metrics & Analysis
Financial Health
Revenue Growth13.20%
Profit Margin29.71%
P/E Ratio52.9
ROE52.24%
ROA15.66%
Debt/Equity12.99
P/B Ratio1410.0
Op. Cash Flow$10.5B
Free Cash Flow$8.2B
Industry P/E39.1
Technical Analysis
TrendBullish
RSI59.4
Support$1,364.81
Resistance$1,603.49
MA 20$1,492.29
MA 50$1,430.39
MA 200$1,172.79
MACDBullish
VolumeIncreasing
Fear & Greed Index91.41
Valuation
Fair Value$497.72
Target Price$1,658.01
Upside/Downside4.15%
GradeOvervalued
TypeGrowth
Dividend Yield0.55%
Risk Assessment
Beta2.09
Volatility50.06%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.